Cancer immunotherapy experience in the Integral Oncology Centre "Diana Laura Riojas de Colosio", Médica Sur Hospital

The useof immunotherapy in Mexico has been used since 2012 with ipilimumab and since 2015 with nivolumab and pembrolizumab, so it is a matter of necessity to know the experience of these drugs. An observational, descriptive, cross-sectional, and retrospective study was performed in Médica Sur Hospit...

Full description

Saved in:

Bibliographic Details
Published in:	Contemporary oncology (Poznan, Poland) Vol. 23; no. 4; pp. 239 - 246
Main Authors:	Fernández-Ferreira, Ricardo, Motola-Kuba, Daniel, Mackinney-Novelo, Ileana, Ruiz-Morales, José Manuel, Torres-Pérez, María Eugenia
Format:	Journal Article
Language:	English
Published:	Poland Termedia Publishing House 01-01-2019
Subjects:	Antigens Bladder cancer cancer Cancer therapies Colorectal cancer Hospitals Hypothyroidism Immunoglobulins Immunotherapy ipilimumab Kidney cancer Laboratories Ligands Lung cancer Melanoma Metastasis Monoclonal antibodies nivolumab Oncology Original Paper pembrolizumab Targeted cancer therapy pembrolizumab cancer nivolumab immunotherapy ipilimumab
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!